Chacon-Cruz Enrique, Martinez-Longoria Cesar Adrian, Llausas-Magana Eduardo, Luevanos-Velazquez Antonio, Vazquez-Narvaez Jorge Alejandro, Beltran Sandra, Limon-Rojas Ana Elena, Urtiz-Jeronimo Fernando, Castaneda-Narvaez Jose Luis, Otero-Mendoza Francisco, Aguilar-Del Real Fernando, Rodriguez-Chagoyan Jesus, Rivas-Landeros Rosa Maria, Volker-Soberanes Maria Luisa, Hinojosa-Robles Rosa Maria, Arzate-Barbosa Patricia, Aviles-Benitez Laura Karina, Elenes-Zamora Fernando Ivan, Becka Chandra M, Ruttimann Ricardo
Hospital General de Tijuana, Paseo Centario S/N, Zona del Rio, Tijuana, 22010, Mexico.
Hospital Universitario 'Dr. Jose Eleuterio Gonzalez,' Monterrey, Nuevo Leon, Mexico.
Ther Adv Vaccines. 2016 Jan;4(1-2):15-9. doi: 10.1177/2051013616650158. Epub 2016 Jan 1.
Meningococcal meningitis is reported as a rare condition in Mexico. There are no internationally published studies on bacterial causes of meningitis in the country based on active surveillance. This study focuses on finding the etiology of bacterial meningitis in children from nine Mexican Hospitals.
From January 2010 to February 2013, we conducted a three years of active surveillance for meningitis in nine hospitals throughout Mexico. Active surveillance started at the emergency department for every suspected case, and microbiological studies confirmed/ruled out all potentially bacterial pathogens. We diagnosed based on routine cultures from blood and cerebrospinal fluid (not polymerase chain reaction or other molecular diagnostic tests), and both pneumococcal serotyping and meningococcal serogrouping by using standard methods.
Neisseria meningitidis was the leading cause, although 75% of cases occurred in the northwest of the country in Tijuana on the US border. Serogroup C was predominant. Streptococcus pneumoniae followed Neisseria meningitides, but was uniformly distributed throughout the country. Serotype 19A was the most incident but before universal implementation of the 13-valent pneumococcal conjugate vaccine. Other bacteria were much less common, including Enterobacteriaceae and Streptococcus agalactiae (these two affecting mostly young infants).
Meningococcal meningitis is endemic in Tijuana, Mexico, and vaccination should be seriously considered in that region. Continuous universal vaccination with the 13-valent pneumococcal conjugate vaccine should be nationally performed, and polymerase chain reaction should be included for bacterial detection in all cultures - negative but presumably bacterial meningitis cases.
在墨西哥,脑膜炎球菌性脑膜炎被报告为一种罕见疾病。目前尚无基于主动监测的关于该国脑膜炎细菌病因的国际发表研究。本研究聚焦于找出墨西哥九家医院儿童细菌性脑膜炎的病因。
2010年1月至2013年2月,我们在墨西哥全国九家医院对脑膜炎进行了为期三年的主动监测。主动监测从急诊科对每例疑似病例开始,微生物学研究确认/排除所有潜在的细菌病原体。我们基于血液和脑脊液的常规培养进行诊断(而非聚合酶链反应或其他分子诊断测试),并使用标准方法进行肺炎球菌血清分型和脑膜炎球菌血清群分型。
脑膜炎奈瑟菌是主要病因,尽管75%的病例发生在该国西北部与美国接壤的蒂华纳。C血清群占主导。肺炎链球菌仅次于脑膜炎奈瑟菌,但在全国分布均匀。19A血清型是最常见的,但这是在13价肺炎球菌结合疫苗普遍接种之前。其他细菌则少见得多,包括肠杆菌科和无乳链球菌(这两种主要影响幼儿)。
脑膜炎球菌性脑膜炎在墨西哥蒂华纳呈地方性流行,该地区应认真考虑接种疫苗。应在全国持续普遍接种13价肺炎球菌结合疫苗,对于所有培养阴性但疑似细菌性脑膜炎的病例,应采用聚合酶链反应进行细菌检测。